Patent Assignment
Reel/Frame 024860/0617
Conversion to a Proprietary Company
Recorded: 2010-08-19
Pages: 2
Assignor
ARANA THERAPEUTICS LIMITED
Executed: 2009-11-27
Assignee
ARANA THERAPEUTICS PTY LTD
LEVEL 2, 37 EPPING ROAD, MACQUARIE PARK, NEW SOUTH WALES, 2113, AUSTRALIA
Covered Property
(1)
Monoclonal Antibody SC104 and Derivative Thereof Specifically Binding to a Sialyltetraosyl Carbohydrate as a Potential Anti-Tumor Therapeutic Agent
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Aug 13, 2007
From: DURRANT, LINDA GILLIAN; PARSONS, TINA
To: SCANCELL LIMITED
Reel/Frame 019683/0206 →
Assignment of Assignor's Interest
Apr 4, 2008
From: SCANCELL LIMITED
To: ARANA THERAPEUTICS LIMITED
Reel/Frame 020758/0837 →
Change of Name
Aug 19, 2010
From: ARANA THERAPEUTICS PTY LTD
To: CEPHALON AUSTRALIA PTY LTD
Reel/Frame 024860/0611 →
Change of Name
Nov 21, 2013
From: CEPHALON AUSTRALIA PTY LTD
To: TEVA PHARMACEUTICALS AUSTRALIA PTY LTD
Reel/Frame 031694/0287 →